Hs00323289_cn

• Gene Symbol: CCDC115
• Assay Reference Genome Location: Chr.2:130338816 on build GRCh38
• Cytoband: 2q21.1

Target Gene Details

• Entrez Gene ID: 84317
• Gene Name: coiled-coil domain containing 115
• Gene Aliases: CDG2O, ccp1
• Location: Chr.2:130337933-130342681 on Build GRCh38
• Assay Gene Location: Within Exon 6

Gene Symbol	Transcript Accession	Exon Location	Assay Transcript Location	Protein ID
CCDC115	NM_001321118.1	5	1284	NP_001308047.1
	NM_001321119.1	5	806	NP_001308048.1
	NM_032357.3	5	1105	NP_115733.2
	NR_104471.1	6	1487
	NR_135548.1	6	1308
	AK054693.1	5	1071	BAB70794.1
	AK092196.1	1	1808
	AK124405.1	2	2993
	AK295922.1	6	1144
	BC006429.1	5	867

Target Copy Number Variation Details

• DGV Version: Release date: 2016-05-15, GRCh GRCh38

Target Variation	Location	CNV Subtype	Genes
nsv998333	Chr.2:130059754 - 130454126 on Build GRCh38	Gain+Loss	TUBA3E IMP4 MZT2B MED15P9 PTPN18 CCDC74B POTEF FAR2P2 SMPD4 NOC2LP1 CCDC115 CYP4F62P
nsv459341	Chr.2:130281566 - 130390535 on Build GRCh38	Loss	IMP4 PTPN18 CCDC115
esv2760631	Chr.2:130005319 - 130400286 on Build GRCh38	Gain+Loss	TUBA3E IMP4 MZT2B MED15P9 PTPN18 CCDC74B POTEF SMPD4 NOC2LP1 FAR2P1 CCDC115
dgv7079n54	Chr.2:130181715 - 130391244 on Build GRCh38	Loss	TUBA3E IMP4 MZT2B PTPN18 SMPD4 NOC2LP1 CCDC115
nsv583113	Chr.2:130132813 - 130369588 on Build GRCh38	Gain	TUBA3E IMP4 MZT2B MED15P9 PTPN18 CCDC74B SMPD4 NOC2LP1 CCDC115
esv3584065	Chr.2:130046530 - 130400286 on Build GRCh38	Loss	TUBA3E IMP4 MZT2B MED15P9 PTPN18 CCDC74B POTEF SMPD4 NOC2LP1 FAR2P1 CCDC115
esv3592452	Chr.2:130316828 - 130342652 on Build GRCh38	Loss	IMP4 CCDC115
nsv520559	Chr.2:130133334 - 130390535 on Build GRCh38	Gain+Loss	TUBA3E IMP4 MZT2B MED15P9 PTPN18 CCDC74B SMPD4 NOC2LP1 CCDC115
nsv1005664	Chr.2:130159287 - 130649604 on Build GRCh38	Loss	IMP4 CFC1 TISP43 PTPN18 FAR2P2 CYP4F62P TUBA3E MZT2B CFC1B SMPD4 LOC107985778 NOC2LP1 CCDC115 POTEI LOC646743 POTEJ
esv2763387	Chr.2:130026123 - 130400286 on Build GRCh38	Loss	TUBA3E IMP4 MZT2B MED15P9 PTPN18 CCDC74B POTEF SMPD4 NOC2LP1 FAR2P1 CCDC115
nsv818080	Chr.2:130185940 - 130352524 on Build GRCh38	Gain	TUBA3E IMP4 MZT2B NOC2LP1 CCDC115
dgv7083n54	Chr.2:130236250 - 130440530 on Build GRCh38	Loss	IMP4 PTPN18 FAR2P2 CCDC115 CYP4F62P
nsv583046	Chr.2:128746961 - 130390535 on Build GRCh38	Loss	IMP4 MED15P9 PTPN18 CCDC74B FAR2P1 LOC151121 TUBA3E MZT2B LOC389033 RAB6C POTEF LOC101927924 LOC101927881 SMPD4 RAB6C-AS1 NOC2LP1 CCDC115
esv3592450	Chr.2:130282861 - 130401532 on Build GRCh38	Loss	IMP4 PTPN18 CCDC115
nsv583132	Chr.2:130255764 - 130390535 on Build GRCh38	Gain	IMP4 PTPN18 CCDC115
nsv1001073	Chr.2:130290533 - 130400286 on Build GRCh38	Gain	IMP4 PTPN18 CCDC115
esv2751826	Chr.2:129606158 - 130385563 on Build GRCh38	Gain	IMP4 MED15P9 PTPN18 CCDC74B FAR2P1 TUBA3E MZT2B LOC389033 RAB6C POTEF LOC101927924 SMPD4 RAB6C-AS1 NOC2LP1 CCDC115
esv2759092	Chr.2:129589265 - 132440430 on Build GRCh38	Gain+Loss	AMER3 IMP4 CCDC74A POTEE TISP43 LINC01087 CYP4F30P TUBA3E MIR4784 RAB6C FAM168B POTEF LOC101927924 LOC440910 SMPD4 LOC107985778 POTEJ C2orf27A C2orf27B CCDC74B FAR2P2 CYP4F62P NOC2LP1 MIR663B WTH3DI MED15P9 CFC1 PTPN18 LOC150776 FAR2P1 ZNF806 ANKRD30BL LOC389033 GPR148 LINC01120 PLEKHB2 CCDC115 MZT2A LOC646743 ARHGEF4 NOC2LP2 FAM201B TUBA3D MZT2B LOC100507460 POTEKP CFC1B GPR39 RAB6C-AS1 POTEI
dgv4073n100	Chr.2:130091652 - 130400286 on Build GRCh38	Gain	TUBA3E IMP4 MZT2B MED15P9 PTPN18 CCDC74B POTEF SMPD4 NOC2LP1 CCDC115
esv3893326	Chr.2:130080351 - 130492798 on Build GRCh38	Gain	IMP4 MED15P9 PTPN18 CCDC74B FAR2P2 CYP4F62P TUBA3E MZT2B POTEF SMPD4 NOC2LP1 CCDC115 POTEI
nsv428403	Chr.2:129818076 - 130882067 on Build GRCh38	Loss	AMER3 IMP4 MED15P9 CFC1 TISP43 PTPN18 CYP4F30P FAR2P1 TUBA3E LOC389033 RAB6C GPR148 POTEF LOC101927924 SMPD4 LOC107985778 CCDC115 LOC646743 ARHGEF4 POTEJ CCDC74B FAR2P2 CYP4F62P MZT2B CFC1B RAB6C-AS1 NOC2LP1 POTEI

More Information

Additional Information:

For this assay, SNP(s) [rs73960308] are located under a primer or probe sequence. To help evaluate the possible impact of a given SNP on your experiment, please refer to the 1000 Genomes and NCBI dbSNP databases. A higher minor allele frequency in your study population represents a higher risk to assay performance.

• Set Membership: Intragenic, Exonic, DGV Variation